SpyGlass Pharma

IPO

SpyGlass Pharma is a biotech company in Aliso Viejo, United States, founded in 2019. It has raised $199.2M across 5 rounds, most recently a $75.0M Series D in June 2025.

Sustained Drug Delivery

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$199.2M
Last Round
$75.0M Series DJun 2025
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 4 investors for this company. The full record is or through the API.

About

SpyGlass Pharma is a late-stage biopharmaceutical company developing implantable ophthalmic drug delivery systems for patients with glaucoma and ocular hypertension. Its BIM-IOL System delivers sustained-release bimatoprost from an intraocular lens implanted during routine cataract surgery, aiming to eliminate lifelong eye drop dependence. The company went public on Nasdaq (SGP) in February 2026.

Summary

It lists 51–200 employees. It has raised $199.2M in total across 5 rounds, most recently a $75.0M Series D round in Jun 2025. Investors include RA Capital Management, Sands Capital and Gilde Healthcare.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOFeb 2026
$150.0M

Sign up to see all 6 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SpyGlass Pharma on Indexed.vc
<a href="https://indexed.vc/companies/spyglass-pharma"><img src="https://indexed.vc/api/badge/company/spyglass-pharma" alt="SpyGlass Pharma on Indexed.vc" width="260" height="76" /></a>